Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Hermes International stock slides as tariff jitters hit luxury shares — what to watch next

Hermes International stock slides as tariff jitters hit luxury shares — what to watch next

Hermès shares fell 3.52% to 2,113 euros in Paris on Monday as U.S. tariff threats triggered a sell-off in European luxury stocks. The euro zone volatility index hit its highest level since November. Trump announced a 10% tariff on several European countries starting Feb. 1, with a possible increase to 25% in June if no Greenland deal is reached. Hermès will report 2025 results on Feb. 12.
19 January 2026
SAP stock drops 3% in Frankfurt as tariff jitters hit tech; Fresenius tie-up and earnings loom

SAP stock drops 3% in Frankfurt as tariff jitters hit tech; Fresenius tie-up and earnings loom

SAP shares fell 3.1% to 195.96 euros in Frankfurt on Monday, hit by a broad tech selloff after U.S. President Trump threatened tariffs on eight European nations. The company announced a digital healthcare partnership with Fresenius, planning a “mid three-digit million euro” investment. SAP’s earnings are due January 29. The STOXX 600 index dropped 1.2%, with tech stocks down 2.9%.
Novo Nordisk stock drops in Copenhagen as Wegovy pill demand gets its first real test

Novo Nordisk stock drops in Copenhagen as Wegovy pill demand gets its first real test

Novo Nordisk B shares fell 2.8% Monday in Copenhagen, closing at 378.15 crowns as investors reacted to early U.S. prescription data for the new oral form of Wegovy. Around 4.7 million shares traded. U.S. prescriptions for oral Wegovy reached nearly 3,100 for the week ending Jan. 9, while overall Wegovy prescriptions dropped 11%. Full-year results are due Feb. 4.
RTX stock at a fresh 52-week high: what to watch before Jan. 27 earnings

RTX stock at a fresh 52-week high: what to watch before Jan. 27 earnings

RTX Corp closed at a new 52-week high of $201.92 Friday, its seventh consecutive gain, after also hitting a fresh intraday peak. U.S. markets were shut Monday for Martin Luther King Jr. Day. Investors await RTX’s fourth-quarter and full-year results on Jan. 27, with attention on guidance and delivery updates. Global risk appetite faded after President Trump revived tariff threats over Greenland.
Wells Fargo stock in focus as Wall Street reopens and Trump’s credit-card rate cap deadline hits

Wells Fargo stock in focus as Wall Street reopens and Trump’s credit-card rate cap deadline hits

Wells Fargo shares closed at $88.38 Friday, down 0.65%, as investors await details on President Trump’s proposal to cap credit card interest rates at 10% starting Jan. 20. U.S. equity futures fell over 1.2% after new tariff threats targeting eight European countries. Wall Street will remain closed Monday for Martin Luther King Jr. Day. Banks say they still lack clarity on how the proposed rate cap would be enforced.
HSBC share price holds near 52-week high as FTSE dips on Trump tariff threat — what to know next

HSBC share price holds near 52-week high as FTSE dips on Trump tariff threat — what to know next

HSBC shares closed up 0.55% at 1,238.8 pence in London, near a 52-week high. The FTSE 100 fell 0.4% after new U.S. tariff threats hit European markets. HSBC confirmed a 6.13% stake in International Personal Finance and set Jan. 23 for a Hong Kong court hearing on Hang Seng Bank’s privatisation. Investors await HSBC’s annual results on Feb. 25.
AstraZeneca share price slips in London as tariff threat rattles markets; EMA review and earnings in focus

AstraZeneca share price slips in London as tariff threat rattles markets; EMA review and earnings in focus

AstraZeneca shares fell 1.15% to 13,890 pence in London as markets reacted to President Trump’s threat of new U.S. tariffs on Britain and other European countries. The FTSE 100 closed down 0.4%. AstraZeneca announced EU validation for Enhertu and a $630 million buyout of China cell-therapy rights. Investors trimmed risk ahead of possible trade retaliation.

Stock Market Today

Stellantis stock slides 24% after €22 billion EV reset kills 2026 dividend — what to watch next

Stellantis stock slides 24% after €22 billion EV reset kills 2026 dividend — what to watch next

7 February 2026
Stellantis shares plunged 23.7% to $7.28 Friday after the company disclosed about €22.2 billion in charges tied to a reset of its electric-vehicle strategy and said it will skip its 2026 dividend. The automaker flagged a preliminary net loss of €19–21 billion for the second half of 2025. Shares rose 1.6% in late after-hours trading. Investors await Feb. 26 results and a May 21 Investor Day.
Intel stock jumps on China server CPU delays as traders map the week ahead

Intel stock jumps on China server CPU delays as traders map the week ahead

7 February 2026
Intel shares rose 4.87% to $50.59 Friday, trailing gains by Nvidia and Broadcom as chip stocks rallied. Sources said Intel and AMD warned Chinese customers of longer waits and higher prices for some server CPUs, with Intel lead times reaching six months. Intel said China accounts for over 20% of its revenue. Investors await key U.S. jobs and inflation data next week.
IRS tax refund delays? Watchdog flags staffing crunch as 2026 filing season ramps up

IRS tax refund delays? Watchdog flags staffing crunch as 2026 filing season ramps up

7 February 2026
IRS staffing has dropped to 2021 levels as the 2026 tax filing season begins, according to a Treasury watchdog. The agency faces a backlog of about 2 million returns, 129% above pre-pandemic levels. Most e-filers using direct deposit still get refunds within 21 days, but paper filings and amended returns could see delays. The IRS lowered its call-answer target to 70% for this season.
Plug Power stock jumps 12% after vote setback, with Feb 17 share decision in focus

Plug Power stock jumps 12% after vote setback, with Feb 17 share decision in focus

7 February 2026
Plug Power shares rose 11.6% Friday to $2.08 after a sharp drop the previous day, as attention shifted to a Feb. 17 shareholder vote on expanding authorized shares. The company failed to secure enough votes earlier this week and is urging overseas holders to participate. CEO Andy Marsh cited difficulties for European investors in casting ballots. A reverse stock split remains possible if the proposal fails.
Go toTop